Bank of Montreal
VIGL

Bank of Montreal’s Vigil Neuroscience VIGL Stock Holding History

Bank of Montreal’s Portfolio VIGL Stock Details VIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-33,368
Closed -$235K – 4272
2024
Q1 		$235K Buy
+33,368
New +$104K ﹤0.01% 2941
2023
Q3 		– Sell
-73,243
Closed -$728K – 4259
2023
Q2 		$728K Buy
73,243
+31,950
+77% +$302K ﹤0.01% 2354
2023
Q1 		$496K Sell
41,293
-16,807
-29% -$189K ﹤0.01% 2466
2022
Q4 		$726K Buy
+58,100
New +$713K ﹤0.01% 2378

Other funds holding VIGL

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

Bank of Montreal's VIGL Position: Q2 2024 in Review

Bank of Montreal sold out of Vigil Neuroscience (VIGL) in Q2 2024, closing a stake of 33,368 shares — an estimated $235K sold.

Bank of Montreal first reported a position in VIGL in Q4 2022 and held it in 4 quarters. The position peaked at $728K in Q2 2023. 58 funds tracked by Wall St. Rank hold VIGL as of Q2 2024.

  • Bank of Montreal reported no remaining Vigil Neuroscience position as of Q2 2024 after selling out during the quarter.
  • Bank of Montreal sold 33,368 Vigil Neuroscience shares in Q2 2024, an estimated $235K.
  • Bank of Montreal first reported a position in Vigil Neuroscience in Q4 2022 and held it in 4 quarters.
  • Bank of Montreal's Vigil Neuroscience position peaked at $728K in Q2 2023.
  • 58 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q2 2024.

Based on Bank of Montreal's 13F filing for Q2 2024, filed 14 Aug 2024.